Pylum Biosciences, Inc.

Overview

Pylum Biosicences has developed and patented an Avidocin™ platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Biological Product (except Diagnostic) Manufacturing325414

Capabilities